Evogene and Compugen Break News

Evogene and Compugen have both made headlines today. The two companies are related - Evogen was spun off of Compugen six years ago as an independent startup. Evogen will receive NIS 7.2 million from venture capital fund AquAgro. The ag-biotech startup develops improved plants for the agricultural and biofuel industries through [...]

In the News: Fixya, Intercure, Mazor, Perytons

According to webware, tech-support startup Fixya will announce a partnership with Best Buy whereby “customers wanting to perform their own fixes (or trying to dig others out of trouble) can go to the Best Buy Web site and access http://geeksquad.fixya.com from the “Customer Service” tab. They can search by product, SKU, manufacturer, or product category, [...]

Israel Delivers: TechnoSpin, Gizmox, Endogun, Applicure

Today Israel’s innovators made all kinds of headlines from cleantech to medical devices to software security.
Let’s start with TechnoSpin. The four year old startup has raised $8 million from US VC 21 Ventures. They develop and produce rotors for small wind turbines which, it claims, are cheaper to produce and more easily assembled than competitor’s [...]

Boston Scientific Abandons Israeli Startups

Boston Scientific will sell its stakes in startup companies, including those in Israeli startups such as superDimension, MEL Medical Enterprises, MediGuide, E-Pill Pharma, Beta O2 Technologies, Brainsgate and VisionCare Ophthalmic Technologies, according to Globes, in order to focus on its core business.
The medical device giant has invested nearly $6 billion in new technologies over the [...]

Evogene and CBD Partner on Cotton Technology

Evogene is an Israeli startup founded in 2002 that aims to generate improved crops and new agricultural biotechnology products in an economically efficient way.  Initially a division of Compugen, Evogene has just signed a partnership with Rehovot-based CBD Technologies, a wholly owned subsidiary of FuturaGene, to collaborate on the improvement of cotton fiber properties.
Under the agreement, CBD [...]

Protalix Gets $4M from Chief Scientist

Protalix BioTherapeutics announced yesterday that it received $4 million from Israel’s Office of the Chief Scientist to help it advance its clinical and pre-clinical drug development programs. The government grant program was setup to aid tech companies that have trouble seeking R&D financing from private investors.
Protalix, which was founded in 1994, intends to use [...]

Surgical Stapler: ES Vascular Raises $3M

ES Vascular has developed highly-advanced surgical staplers for endovascular surgery, open aortic surgery and critical limb ischemia (CLI). Private investors have now invested $3 million in hopes that the company’s Open Aortic Stapler will soon receive the CE mark which will allow it to begin marketing in Europe. The money should also [...]

New Technology May Increase Organ Transplants

Israeli biotech company Core Dynamics has released the results of a study this month that demonstrate the feasibility of recovering a functional heart after it has been frozen and then thawed. Its unique controlled freezing method, which is based on the Company’s patented Multi Thermal Gradient (MTG) freezing technology, reduces the damage to cells [...]

Modigene Raises $2M with More on the Way

Modigene Inc. is a biopharmaceutical company founded in Israel in 2001 that has developed technology that creates longer-lasting, proprietary versions of already approved therapeutic proteins. One of these therapeutic proteins is FHS, a naturally occurring female hormone that can be added as a supplement to women with fertility problems to increase their chances of [...]

Positive Results for BioLineRx Heart Attack Treatment

BioLineRx, an Israeli drug development company, has announced that the first heart attack patient has emerged unscathed from a Phase 1/2 clinical trial study of its BL-1040, a breakthrough approach to supporting damaged cardiac tissue. The trial is using up to 30 patients in several sites in Germany, Belgium and Israel and is designed [...]